Table 5.
Other outcomes.
| Study | Group 1, % avascular necrosis |
Group 2, % avascular necrosis |
Group 1, % revision (min) |
Group 2, % revision |
Group 1, % infection (min) |
Group 2, % infection |
Group 1, operative time |
Group 2, operative time |
Group 1, Functional outcomes (Friedman and Wyman). Patients/Category |
Group 2, Functional outcomes (Friedman and Wyman). Patients/Category |
|---|---|---|---|---|---|---|---|---|---|---|
| Mohapatra 201734 | 10% (1/10) | 0% (0/8) | N/A | N/A | N/A | N/A | 90 (80-130) | 75 | Good: 7 Fair: 1 Poor: 2 | Good: 6 Fair: 2 Poor: 0 |
| Kharel 201733 | 0% (0/11) | 0% (0/13) | N/A | N/A | N/A | N/A | 96 | 75 | Good: 8 Fair: 2 Poor: 1 | Good: 8 Fair: 4 Poor: 1 |
| Mardani-Kivi 201432 | 6.67% (1/15) | 26.3% (5/19) | N/A | N/A | N/A | N/A | 76 (±7.83) | 99.21 (±11/45) | Good: 13 Fair: 2 Poor: 0 | Good: 14 Fair: 4 Poor: 1 |
| Wang 201015 | 0% (0/10) | 0% (0/11) | 0% (0/10) | 9.1% (1/11) | 10% (1/10-Superficial) | 9.1% (1/11-Deep) | 217 (155-335) | 255 (215-230) | Good: 8 Fair: 1 Poor: 1 | Good: 8 Fair: 2 Poor: 1 |
| Tsai 20099 | 0% (0/5) | 5.26% (2/38) | 0% (0/5) | 7.9% (3/38) | 0% (0/5) | 0% (0/38) | 301 (180-480) | 278 | Good: 4 Fair: 1 Poor: 0 | Good: 29 Fair: 7 Poor: 2 |
| Singh 200819 | 13.6% (3/12) | 0% (0/15) | 25% (3/12) | 0% (0/15) | N/A | N/A | 115.2 (75-139) | 72.5 (59-88) | Good: 10 Fair: 1 Poor: 1 | Good: 13 Fair: 1 Poor: 1 |